ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01623115
Brief Title: Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy (ODYSSEY FH I)

First Submitted : June 15, 2012
First Submitted that Met QC Criteria : June 18, 2012
First Posted : June 19, 2012 (Estimate)

Results First Submitted : August 20, 2015
Results First Submitted that Met QC Criteria : October 7, 2015
Results First Posted : November 4, 2015 (Estimate)

Certification/Extension First Submitted : February 9, 2015
Certification/Extension First Submitted that Met QC Criteria : February 9, 2015
Certification/Extension First Posted : February 27, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 11, 2016
Last Update Posted : February 8, 2016 (Estimate)